Literature DB >> 24881074

Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines.

Vincent Cottin1, Bruno Crestani2, Dominique Valeyre2, Benoit Wallaert2, Jacques Cadranel2, Jean-Charles Dalphin2, Philippe Delaval2, Dominique Israel-Biet2, Romain Kessler2, Martine Reynaud-Gaubert2, Bernard Aguilaniu2, Benoit Bouquillon2, Philippe Carré2, Claire Danel2, Jean-Baptiste Faivre2, Gilbert Ferretti2, Nicolas Just2, Serge Kouzan2, François Lebargy2, Sylvain Marchand-Adam2, Bruno Philippe2, Grégoire Prévot2, Bruno Stach2, Françoise Thivolet-Béjui2, Jean-François Cordier2.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is the most frequent chronic idiopathic interstitial pneumonia in adults. The management of rare diseases in France has been organised by a national plan for rare diseases, which endorsed a network of expert centres for rare diseases throughout France. This article is an overview of the executive summary of the French guidelines for the management of IPF, an initiative that emanated from the French National Reference Centre and the Network of Regional Competence Centres for Rare Lung Diseases. This review aims at providing pulmonologists with a document that: 1) combines the current available evidence; 2) reviews practical modalities of diagnosis and management of IPF; and 3) is adapted to everyday medical practice. The French practical guidelines result from the combined efforts of a coordination committee, a writing committee and a multidisciplinary review panel, following recommendations from the Haute Autorité de Santé. All recommendations included in this article received at least 90% agreement by the reviewing panel. Herein, we summarise the main conclusions and practical recommendations of the French guidelines. ©ERS 2014.

Entities:  

Mesh:

Year:  2014        PMID: 24881074     DOI: 10.1183/09059180.00001814

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  18 in total

Review 1.  Idiopathic pulmonary fibrosis in East Asian.

Authors:  Changbo Sun; Yanbin Sun; Hui Shen; Chunlu Yang; Shun Xu
Journal:  Intractable Rare Dis Res       Date:  2017-05

2.  French recommendations for the management of systemic sclerosis.

Authors:  Eric Hachulla; Christian Agard; Yannick Allanore; Jerome Avouac; Brigitte Bader-Meunier; Alexandre Belot; Alice Berezne; Anne-Sophie Bouthors; Geraldine Condette-Wojtasik; Joël Constans; Pascal De Groote; Elisabeth Diot; Florence Dumas; Patrick Jego; Francisca Joly; David Launay; Veronique Le Guern; Janine-Sophie Le Quintrec; Geraldine Lescaille; Christophe Meune; Bruno Moulin; Christelle Nguyen; Nadine Omeish; Frederic Pene; Marie-Aleth Richard; Juliette Rochefort; Alexandra Roren; Olivier Sitbon; Vincent Sobanski; Marie-Elise Truchetet; Luc Mouthon
Journal:  Orphanet J Rare Dis       Date:  2021-07-26       Impact factor: 4.123

Review 3.  Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic age.

Authors:  Jonathon Shaw; Tracey Marshall; Helen Morris; Conal Hayton; Nazia Chaudhuri
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 4.  Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.

Authors:  Maya M Juarez; Andrew L Chan; Andrew G Norris; Brian M Morrissey; Timothy E Albertson
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

5.  Dramatic improvement of anti-SS-A/Ro-associated interstitial lung disease after immunosuppressive treatment.

Authors:  Caramaschi Paola; Festi Giuliana; Orsolini Giovanni; Caimmi Cristian; Biasi Domenico
Journal:  Rheumatol Int       Date:  2016-03-28       Impact factor: 2.631

Review 6.  The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.

Authors:  Fernando J Martinez; Alison Chisholm; Harold R Collard; Kevin R Flaherty; Jeffrey Myers; Ganesh Raghu; Simon L F Walsh; Eric S White; Luca Richeldi
Journal:  Lancet Respir Med       Date:  2016-12-06       Impact factor: 30.700

7.  Spontaneous ventilation anesthesia combined with uniportal and tubeless thoracoscopic lung biopsy in selected patients with interstitial lung diseases.

Authors:  Guilin Peng; Mengyang Liu; Qun Luo; Hanzhang Chen; Weiqiang Yin; Wei Wang; Jun Huang; Yuan Qiu; Zhihua Guo; Lixia Liang; Qinglong Dong; Xin Xu; Jianxing He
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

8.  Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases.

Authors:  Mouhamad Nasser; Marion Colevray; Salim A Si-Mohamed; Olivier Nempont; Pierre-Jean Lartaud; Anna Vlachomitrou; Thomas Broussaud; Kais Ahmad; Julie Traclet; Vincent Cottin; Loic Boussel
Journal:  Eur Radiol       Date:  2022-01-14       Impact factor: 7.034

9.  A Review of the Multidisciplinary Diagnosis of Interstitial Lung Diseases: A Retrospective Analysis in a Single UK Specialist Centre.

Authors:  Nazia Chaudhuri; Lisa Spencer; Melanie Greaves; Paul Bishop; Anshuman Chaturvedi; Colm Leonard
Journal:  J Clin Med       Date:  2016-07-27       Impact factor: 4.241

10.  Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study.

Authors:  Jun Fukihara; Hiroyuki Taniguchi; Masahiko Ando; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Taiki Furukawa; Takeshi Johkoh; Junya Fukuoka; Koji Sakamoto; Yoshinori Hasegawa
Journal:  BMC Pulm Med       Date:  2017-02-06       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.